Drugs News and Research

RSS

IRIN examines Lancet series on TB

IRIN examines The Lancet series on tuberculosis, saying that authors writing in the collection of articles note that investments in TB since 1993, when the WHO declared the disease a global emergency, "have led to the most promising pool of new tuberculosis drug and vaccine candidates in more than 40 years, with several new drugs and drug regimens poised to enter late-stage clinical trials throughout the next few years."

28 Mar 2013

TSRI scientists awarded innovative grant to develop anti-smoking drug candidates

As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of The Scripps Research Institute have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.

28 Mar 2013

Virginia G. Piper Cancer Center Clinical Trials successfully tests cabozantinib

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute.

28 Mar 2013

Smokers trying to quit will have better experience with varenicline, study finds

Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline compared to bupropion and to placebo - unmedicated assisted smoking cessation -according to a study published in the journal JAMA Psychiatry.

28 Mar 2013

New study associates commonly used diabetes drugs with pancreatic cancer risk

ndividuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine tumors, according to a new study by researchers from UCLA and the University of Florida.

28 Mar 2013

Researchers reprogramming skin cells into brain cells to understand Alzheimer's disease

Sam Gandy, MD, PhD, of the Icahn School of Medicine at Mount Sinai is leading an international team of researchers working to reprogram skin cells into brain cells to gain a better understanding of Alzheimer's disease.

28 Mar 2013

Pancreatic cancer cells' growth are fueled by metabolic pathway, scientists find

Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.

28 Mar 2013

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

Patients receiving antihistamines to suppress stomach acid are at greater risk of infection from Clostridium difficile, or C. diff, a common cause of diarrhea, particularly in health care settings, Mayo Clinic researchers have found.

28 Mar 2013

National Rx Drug Abuse Summit to make impact on America's prescription drug problem

The prescription drug epidemic continues to take lives in America, causing 100 overdose deaths daily, according to the Centers for Disease Control and Prevention.

27 Mar 2013

Royal Holloway University supports Muscular Dystrophy Campaign

Royal Holloway University, is today giving money generated by its research into Duchenne muscular dystrophy to the Muscular Dystrophy Campaign.

27 Mar 2013

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to carbapenems.

27 Mar 2013

Lancet series examines tuberculosis

"To commemorate World TB Day 2013, the Lancet Infectious Diseases publishes a series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO," the series homepage states.

27 Mar 2013

Biological scientists lead major research project that aims to make drugs more effective

University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.

27 Mar 2013

New research may shed light on alcohol addiction vulnerability in some people

A Wake Forest Baptist Medical Center team studying alcohol addiction has new research that might shed light on why some drinkers are more susceptible to addiction than others.

27 Mar 2013

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

"The Indonesian government hopes to implement one of the largest ever examples of 'compulsory licensing,' which will enable the generic manufacture of drugs still under patent," IRIN reports.

27 Mar 2013

CHOP researchers moving closer to personalized medicine for children with cancer

Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments.

27 Mar 2013

Study suggests possibility of engineering artificial ovaries in lab

A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women.

27 Mar 2013

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

From Clinigen Group 26 Mar 2013

Challenges remain in fight against TB, U.N. Secretary-General says

On World Tuberculosis Day, recognized on March 24, U.N. Secretary-General Ban Ki-moon "said that while there has been much progress since the World Health Organization declared TB a global health emergency two decades ago, there are still challenges to be met, mainly stopping the spread of multidrug-resistant TB, also known as MDR-TB, which threatens to reverse the gains achieved in past years," the U.N. News Centre reports.

26 Mar 2013

Eating behavior could act as defense mechanism against infections and autoimmune disorders

Neurons that control hunger in the central nervous system also regulate immune cell functions, implicating eating behavior as a defense against infections and autoimmune disease development, Yale School of Medicine researchers have found in a new study published in the Proceedings of the National Academy of Sciences (PNAS).

26 Mar 2013

Drugs News and Research

IRIN examines Lancet series on TB

TSRI scientists awarded innovative grant to develop anti-smoking drug candidates

Virginia G. Piper Cancer Center Clinical Trials successfully tests cabozantinib

Smokers trying to quit will have better experience with varenicline, study finds

New study associates commonly used diabetes drugs with pancreatic cancer risk

Researchers reprogramming skin cells into brain cells to understand Alzheimer's disease

Pancreatic cancer cells' growth are fueled by metabolic pathway, scientists find

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

National Rx Drug Abuse Summit to make impact on America's prescription drug problem

Royal Holloway University supports Muscular Dystrophy Campaign

Microbiologists identify unique resistance mechanisms of E. coli to carbapenems

Lancet series examines tuberculosis

Biological scientists lead major research project that aims to make drugs more effective

New research may shed light on alcohol addiction vulnerability in some people

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

CHOP researchers moving closer to personalized medicine for children with cancer

Study suggests possibility of engineering artificial ovaries in lab

Clinigen announces acquisition of Cardioxane from Novartis

Challenges remain in fight against TB, U.N. Secretary-General says

Eating behavior could act as defense mechanism against infections and autoimmune disorders

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News